Rx-TO-OTC SWITCHES WOULD BE DISCOURAGED BY FDA USER FEES, P-A's O'KEEFE TELLS HOUSE BUDGET HEARING; IBA NOTES DETERRENT EFFECT ON SMALL BUSINESS